Counsel patients that tirzepatide treats obesity as a chronic disease requiring ongoing management, similar to medications for hypertension or diabetes
Vitamin B 12is not present in foods of plant origin, but is abundant in foods of animal origin
Physical ability increased by 21%
Liraglutide, a long-acting GLP-1 agonist, is also approved as adjunct pharmacotherapy with lifestyle modification for weight management, particularly for patients with BMI 27 kg/m2, with or without T2DM
Your appeal should include: A letter of medical necessity from your prescriber citing your BMI, comorbidities, and prior weight-loss attempts Relevant lab work (fasting glucose, HbA1c, lipid panel) that documents obesity-related metabolic dysfunction Reference to the SELECT trial or the STEP program data showing the clinical benefit of semaglutide 2.4 mg